Abstract
HTA334 Assessment of Vaccines in Europe, the HPV Example: Can the EU Joint Clinical HTA Regulation Result in More Consistent Vaccine Evaluations and Improve Access Across EU Countries?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have